Ambu CEO promises more growth in legacy business: "Not prioritized enough"
Ambu must be careful not to overly de-prioritize its original core business of anesthesia and patient monitoring in its eagerness to generate profitable growth in the medical device company’s new focus area of single-use endoscopy.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Ambu gets a new vice chairman
For subscribers
Ambu gets US special status for bronchoscope
For subscribers
Ambu receives European approval for ureteroscopy products
For subscribers